share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director NORA JOHNSON SUZANNE M

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director NORA JOHNSON SUZANNE M

辉瑞 | 4：持股变动声明-董事 NORA JOHNSON SUZANNE M
美股sec公告 ·  04/26 13:28
Moomoo AI 已提取核心信息
Suzanne M. Nora Johnson, a reporting person for Pfizer Inc [PFE], was involved in a transaction on April 25, 2024. The specific details regarding the nature of the transaction, including the number of shares, transaction price, and total value, have not been disclosed. The action type and status, as well as the number of shares held after the action, are also not provided in the announcement. Investors are advised to seek additional information to fully understand the impact of this event on their investment decisions.
Suzanne M. Nora Johnson, a reporting person for Pfizer Inc [PFE], was involved in a transaction on April 25, 2024. The specific details regarding the nature of the transaction, including the number of shares, transaction price, and total value, have not been disclosed. The action type and status, as well as the number of shares held after the action, are also not provided in the announcement. Investors are advised to seek additional information to fully understand the impact of this event on their investment decisions.
辉瑞公司 [PFE] 的举报人苏珊娜·诺拉·约翰逊于2024年4月25日参与了一笔交易。有关交易性质的具体细节，包括股票数量、交易价格和总价值，尚未披露。公告中也未提供行动类型和状态以及行动后持有的股票数量。建议投资者寻求更多信息，以充分了解这一事件对其投资决策的影响。
辉瑞公司 [PFE] 的举报人苏珊娜·诺拉·约翰逊于2024年4月25日参与了一笔交易。有关交易性质的具体细节，包括股票数量、交易价格和总价值，尚未披露。公告中也未提供行动类型和状态以及行动后持有的股票数量。建议投资者寻求更多信息，以充分了解这一事件对其投资决策的影响。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息